Navigation Links
Dr. Peter C. Neligan, Author of 3rd Edition of Elsevier's Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
Date:11/27/2012

PHILADELPHIA, Nov. 27, 2012 /PRNewswire/ -- In the wake of the passing of Nobel Prize winning surgeon Dr. Joseph Murray, who carried out the first successful kidney transplant in 1954, Dr. Peter C. Neligan, author of the definitive textbook of the discipline, Plastic Surgery, (3rd Ed., Elsevier, October 2012) is available to comment on Dr. Murray's legacy of innovation. Dr. Murray died on Monday in Boston at the age of 93.

"The history of Plastic Surgery is one of innovation in medicine, and Dr. Murray's contributions paved the way for developments that today continue in areas such as hand and face transplantation," says Dr. Neligan, author of five books, more than 50 book chapters and 170 peer-reviewed papers.

A professor of Plastic Surgery and Otolaryngology/Neck Surgery at the University of Washington Medical Center in Seattle, Dr. Neligan spent four years editing Plastic Surgery, working with the Elsevier team and with the volume editors. The 6-volume text is the first update in a decade, and includes 160 videos and online resources that bring the latest techniques to the practitioner's iPad or cell phone.

"Many people think of plastic surgery as a cosmetic practice, but Aesthetic Surgery fills only one of the six volumes in the Plastic Surgery text," Dr. Neligan says. "Plastic Surgeons are leading the way with new developments in stem cell therapy, tissue engineering, and inductive therapies; aesthetic surgical techniques and nonsurgical treatments; conjoined twin separation and other craniofacial surgery advances; microsurgical lymphatic reconstruction, super microsurgery, nerve transfers in hand surgery, functional prosthetics, and more."

Additional information about Dr. Neligan and Plastic Surgery is available at http://elsevierauthors.com/peterneligan.



'/>"/>
SOURCE Elsevier, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
2. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
3. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
4. Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
5. Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations
6. Auditors Complete Kansas Bioscience Authority Forensic Audits
7. Dietary Supplements Extensively Regulated, Say Authors of New Article
8. Fitzsimons Redevelopment Authority Names New President & CEO
9. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Swedesboro, NJ (PRWEB) May 24, 2013 Dr. ... Elmer, NJ and Swedesboro, NJ, are proud to announce an ... event will take place on Saturday, June 8th from 10 ... Dr. Warmuth, Anamaria Newport, MHS, PA-C and staff will be ... dermal fillers, laser and aesthetic treatments, and provide complimentary cosmetic ...
(Date:5/24/2013)... May 24, 2013 In a ... industry suppliers will present technologies with applications in ... annual SPIE Optics and Photonics symposium ... SPIE, the international society for optics and ... multidisciplinary optical sciences and technology meeting in North ...
(Date:5/24/2013)... May 24, 2013 Bed bug cases tend ... themselves from the looming higher risk of becoming the pests' ... new bed bug guideline. In the guide, the company enumerated ... and avoiding them while traveling. , According to My ... increase of bed bug infestation during summer: the warm weather ...
(Date:5/24/2013)... Israel , May 24, 2013 ... leader in embolic protection stents, announced that Alan ... and Craig Shore , the Company,s Chief ... Investor Conference on Thursday May 30, 2013 at The Pfister ... The format of the conference includes a ...
Breaking Biology Technology:See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4
... N.J., Feb. 5 Genta,Incorporated (Nasdaq: GNTA ) ... Dr. Raymond P. Warrell, Jr., will provide a,company overview ... &,Investor Conference. The presentation is scheduled for Wednesday, February,13th ... New York, NY., About Genta, Genta Incorporated ...
... LOUISVILLE, Colo., Feb. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... February 26, 2008 at 4:45 P.M. ET to report 2007 ... upcoming,investor conference in February 2008., Earnings conference call ... President and CEO, and other members of Replidyne,s ...
... Mass., Feb. 5 Echo Therapeutics,Inc. (OTC Bulletin ... announced today that Patrick T. Mooney, M.D, Chairman,and ... Small-Cap Investor,Conference on February 7, 2008 at 3:50 ... The conference will be held at the Four ...
Cached Biology Technology:Genta Incorporated to Present at the BIO CEO & Investor Conference 2Genta Incorporated to Present at the BIO CEO & Investor Conference 3Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3Echo Therapeutics to Present at RedChip Small-Cap Investor Conference 2
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
(Date:5/23/2013)... the overall health, development, and academic success of ... ensuring that all students have opportunities to engage ... vigorous or moderate-intensity physical activity, says a new ... estimates suggest that only about half of school-age ... health and development. The report recommends that ...
(Date:5/23/2013)... cerebral palsy with autologous cord blood. Following a cardiac ... boy had been in a persistent vegetative state ... treatment with the cord blood containing stem cells, the ... learned to speak simple sentences and to move. "Our ... the long-held doubts about the effectiveness of the new ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... November 18, 2008 -- Researchers at the University of California, ... been used to block and reverse type 1 diabetes in ... the National Academy of Sciences , was led by Jeffrey ... an expert in the field of autoimmunity. "The findings ...
... at Birmingham (UAB) Center for Education and Research on ... to study the risks and benefits of a newer ... therapies that target the immune system of patients who ... disorders. The award will allow the UAB CERTs ...
... WEST LAFAYETTE, Ind. - Materials engineers have created a ... and, if perfected, might be used for environmental cleanup, ... would last longer than conventional filters for separating oil ... oil, traits that are usually mutually exclusive. Researchers attached ...
Cached Biology News:Musculoskeletal center wins $2.2 million for drug safety 2New filtering technology has environmental, industrial applications 2New filtering technology has environmental, industrial applications 3
... optically clear polystyrene formulation , High antibody-binding ... , Plates are certified for performance ... , Eight-well strips fit snugly in ... in use even if turned upside down ...
...
... an aqueous solution that contains a purified ... in a saline solution, pH 6.5 ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ... and stabilizer for biologically active components in ...
... StabilGuard Biomolecule Stabilizer is a bovine protein-free ... is an aqueous solution that contains non-toxic ... saline), pH 6.6 - 7.2, and does ... maintains the activity of antibodies and other ...
Biology Products: